Comprehensive Study Notes on Respiratory Pharmacology: Histamine, Antihistamines, and Clinical Nursing Considerations

Histamine Pathophysiology and Allergic Reactions

  • Histamine Function and Mast Cell Release:

    • Histamine serves as a major inflammatory mediator in numerous allergic disorders.
    • Released directly from mast cells during immune-mediated allergic reactions.
    • Exerts potent physiological effects on the vascular system and secretory glands by dilating blood vessels, increasing vascular permeability, and stimulating secretions.
  • Allergic Disorders Mediated by Histamine:

    • Allergic rhinitis
    • Anaphylaxis
    • Angioedema
    • Drug fevers
    • Insect bite reactions
    • Urticana (urticaria)
  • Pathophysiological Mechanisms of Anaphylaxis:

    • Defined as a severe, life-threatening systemic allergic reaction triggered by the rapid release of excessive amounts of histamine.
    • Smooth Muscle Constriction: Causes acute constriction of smooth muscle tissue, particularly in the lungs (bronchoconstriction) and the stomach.
    • Secretory Hyperactivity: Drives a marked increase in body secretions across organ systems.
    • Vascular Collapse: Causes severe systemic vasodilation combined with increased capillary permeability.
    • Fluid Extravasation: Increased permeability results in the rapid movement of fluid out of the blood vessels and into the interstitial tissues.
    • Hemodynamic and Tissue Consequences: Leads directly to a profound drop in blood pressure (BP) (hypotension) and extensive, widespread edema.

Histamine Receptor Blockers and Classification

  • H1H_1 Receptor Antagonists (H1H_1 Blockers):

    • Indicated primarily for inflammatory, allergic, and respiratory symptoms.
    • Fexofenadine (trade name: Allegraj / Allegra)
    • Loratadine (trade name: Claritin)
    • Cetirizine (trade name: Reactine)
    • Diphenhydramine (trade name: Benadryl)
  • H2H_2 Receptor Antagonists (H2H_2 Blockers):

    • Clinical role centers on gastric acid reduction in peptic ulcer disease.
    • Cimetidine
    • Ranitidine (trade name: zantac)
    • Famotidine (trade name: Pepcid AC)
    • Nizatidine (trade name: Axid)

Mechanisms of Action and Physiological Effects

  • Antihistamine Mechanism of Action (MOA):

    • Competitively block the physiological action of histamine at target H1H_1 receptor sites.
    • The binding of receptor blockers to histamine receptors prevents the adverse consequences normally induced by histamine stimulation.
    • By occupying histamine receptors prior to histamine attachment, these agents prevent endogenous histamine from precipitating acute allergic responses.
  • Comparison of Histamine Stimulation vs. Antihistamine Intervention:

    • Vascular Effects:
    • Histamine: Promotes profound vasodilation and significantly increases capillary permeability, driving fluid shift and edema.
    • Antihistamines: Bind to histamine receptors to counteract histamine stimulation, modulating vascular reactivity and reducing hyperpermeability.
    • Secretory Effects:
    • Histamine: Powerfully stimulates secretions across multiple organ networks, including the gastrointestinal (GI) tract, respiratory tract, salivary glands, and lacrimal glands.
    • Antihistamines: Significantly reduce excessive bodily secretions across salivary, lacrimal, gastrointestinal, and respiratory tissues.

Indications and Clinical Applications

  • Core Therapeutic Indications:
    • Allergies: Relief of systemic and local hypersensitivity reactions, allergic rhinitis, and histamine-mediated dermatologic responses.
    • Motion Sickness: Prevention and treatment of nausea and equilibrium disturbances associated with motion.
    • Parkinson's Disease: Used as an adjunct intervention in managing specific motor and neurological manifestations.
    • Vertigo: Alleviation of vestibular imbalance and spinning sensations.
    • Sleep Disorders: Used for sedative properties to treat insomnia and facilitate sleep onset.
    • Common Cold: Administered to relieve cold symptoms, such as rhinorrhea and hypersecretion.

Clinical Contraindications and Precautions

  • Conditions Warranting Strict Contraindication or Cautious Administration (*Use w/ caution):
    • Acute Angle Glaucoma: Risk of anticholinergic-induced pupillary dilation and increased intraocular pressure.
    • Cardiac Disease / Hypertension (HTN): Risk of hemodynamic instability, tachycardia, or exacerbated hypertension.
    • Kidney Disease: Altered renal clearance leading to drug accumulation and heightened toxicity.
    • Bronchial Asthma / COPD: Drying of secretions and potential worsening of airway compromise.
    • Peptic Ulcer Disease: Requires caution, particularly when balancing histamine-receptor dynamics.
    • Seizure Disorders: Lowered seizure threshold associated with certain central antihistaminergic agents.
    • Benign Prostatic Hyperplasia (BPH): Anticholinergic urinary retention risks exacerbating bladder outlet obstruction.
    • Pregnancy: Potential teratogenic or perinatal risks warranting careful risk-benefit evaluation.

Adverse Effects and Nonsedating Formulations

  • Spectrum of Adverse Effects:

    • Anticholinergic Side Effects:
    • Dry mouth (xerostomia)
    • Difficulty urinating (urinary retention / hesitation)
    • Constipation
    • Vision changes (such as blurred vision secondary to pupillary changes)
    • Central Nervous System Depressant Effects:
    • Significant drowsiness!
    • Can induce a sedative continuum ranging from mild drowsiness to deep sleep.
  • Nonsedating Antihistamines:

    • Pharmacodynamics: Work peripherally to selectively block the actions of histamine, preventing major penetration across the blood-brain barrier.
    • Tolerability Advantage: Cause significantly fewer central nervous system (CNS) side effects (markedly reduced sedation and cognitive slowing).
    • Pharmacokinetics: Feature a longer duration of action compared to older first-generation agents, supporting once-daily or less frequent dosing regimens.
    • Specific Nonsedating Agents:
    • Loratadine
    • Cetirizine
    • Fexofenadine

Critical Warnings for Acute Respiratory Emergencies

  • Lower Respiratory Disease Precautions:

    • Use extreme caution and observe specific restrictions in the presence of lower respiratory diseases, such as pneumonia.
  • Absolute Restriction in Acute Asthmatic Attacks:

    • Antihistamines are strictly contraindicated as the sole drug therapy during acute asthmatic attacks.
    • Antihistamines do not produce rapid, direct bronchodilation required to resolve acute airway obstruction and bronchospasm.
  • Emergency Rescue Pharmacotherapy:

    • Acute bronchospasm and severe anaphylactic attacks require immediate emergency bronchodilators and adrenergic agonists:
    • Salbutamol (Lysalbutamol)
    • Epinephrine (Lepinephnhe)

Patient Education and Nursing Care

  • Monitoring and Immediate Reporting:

    • Educate the patient to monitor for and immediately report excessive sedation, acute confusion, or signs of hypotension (abnormal drop in blood pressure).
  • Safety and Activity Restrictions:

    • Instruct the patient to avoid driving (cirining), operating machinery, consuming alcohol, or ingesting concurrent CNS depressants due to compounding sedative and psychomotor impairment.
  • Drug Interactions and Physician Consultation:

    • Advise patients never to combine antihistamines with other medications without first checking with a doctor.
  • Administration Technique:

    • Instruct patients to take medication with food to prevent gastrointestinal upset.
  • Management Strategies for Dry Mouth:

    • Perform diligent, regular mouth care.
    • Chew gum to stimulate salivary flow.
    • Suck on hard candy to alleviate xerostomia.